期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血液恶性肿瘤诊治的研究趋势 被引量：3

原文传递
导出
摘要 血液恶性肿瘤如白血病、淋巴瘤、多发性骨髓瘤是严重危害人们身心健康的重大疾病。近几十年来，诊疗技术的进展使血液病的疗效有了较大提高，血液恶性肿瘤从之前的不可治愈，到现在越来越多的类型可以治愈，例如急性早幼粒细胞白血病（APL），由原来的生存率不足20％上升至90％以上。这些成绩的取得，归因于以下3个方面。
作者 黄晓军
机构地区 北京大学人民医院、北京大学血液病研究所造血干细胞移植治疗血液病北京市重点实验室
出处 《中华内科杂志》 CAS CSCD 北大核心 2012年第9期739-741,共3页 Chinese Journal of Internal Medicine
基金 基金项目：北京市科技计划项目（Z111107067311070） 北京市自然科学基金面上项目（7122193）
关键词 血液恶性肿瘤 急性早幼粒细胞白血病 肿瘤诊治 多发性骨髓瘤 重大疾病 身心健康 诊疗技术 淋巴瘤
分类号 R733 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Wang ZY, Chen Z. Acute promyelocytie leukemia: from highly fatal to highly curable. Blood, 2008,11 1 :2505-2515.
  • 2Lu DP, Qiu JY, Jiang B, et al. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood, 2002,99:3136-3143.
  • 3Donnel MRO, Abboud CN, Altman J, et al. The NCCN clinical practice guidelines in oncology (NCCN Guidelines TM ) acute myelogenous leukemia [ R/OL 1. [ 2001--04-10 ]. http://www. nccn. org/profession/s/physician g|s/pdf/cm|, pdf.
  • 4Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program, 2009, 2009 : 385-395.
  • 5Foran JM. New prognostic markers in acute myeloid leukemia: perspective from the clinic. Hematology Am Soc Hematol Educ Program, 2010, 2010:47-55.
  • 6Figueroa ME, Lugthart S, Li Y, et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell, 2010,17 : 13-27.
  • 7Deininger M, O' Brien SG, Guilhot F, et al. International randomized study of interferon vs STI571 (IRIS) 8-year follow up : sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib. 51st ASH Annual Meeting and Exposition Abstracts, New Orleans, US, 2008. New Orleans: American Society of Hematology ,2008 : 186.
  • 8Avvisati G, Petti MC, Lo-Coeo F, et al. Induction therapy with idarubiein alone significantly influences event-free survival duration in patients with newly diagnosed hypergranuIar acute promyeloeytie leukemia: final results of the GIMEiVIA randomized study LAP 0389 with 7 years of minimal follow-up. Blood, 2002, 100:3141-3146.
  • 9Jiag Q, Xu LP, Liu DH, et al. Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase. Blood, 2011,117:3032-3040.
  • 10Santos FP, Verstovsek S. JAK2 inhibitors: what's the true therapeutic potential? Blood Rev, 2011,25:53-63.

二级参考文献19

  • 1高晓东,吴文,唐帏,闫骅,徐岚,沈志祥,胡炯,赵维莅.造血干细胞移植患者血清IL-2及其受体检测的临床意义[J].中国实验诊断学,2006,10(12):1477-1479. 被引量：2
  • 2张荣莉,冯四洲,杨栋林,阎嶂松,姜尔烈,黄勇,刘庆国,韩明哲.血清细胞因子水平与急性移植物抗宿主病的关系[J].肿瘤,2007,27(5):409-411. 被引量：1
  • 3柳金,张献共,陆道培.同种异基因造血干细胞移植受者血清白介素18水平与急性移植物抗宿主病的关系[J].中国实验血液学杂志,2007,15(3):553-557. 被引量：5
  • 4Martin PJ,Schoch G,Fisher L,et al.A retrospective analysis of therapy for acute graft-versus-host disease:secondary treatment.Blood,1991,77:1821-1828.
  • 5Huang XJ,Wan J,Lu DP.Serum TNFalpha levels in patients with acute graft-versus-host disease after bone marrow transplantation.Leukemia,2001,15:1089-1091.
  • 6Shaiegan M,Iravani M,Babaee GR,et al.Effect of IL-18 and sIL-2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.Transplant Immunol,2006,15:223 -227.
  • 7Grimm J,Zeller W,Zander AR.Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD.Bone Marrow Transplant,1998,21:29-32.
  • 8Visentainer JE,Lieber SR,Persoli LB,et al.Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.Exp Hematol,2003,31:1044-1050.
  • 9Ju XP,Xu B,Xiao ZP,et al.Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation.Bone Marrow Transplant,2005,35:1179-1186.
  • 10Roy J,Blazar BR,Ochs L,et al.The tissue expression of cytokines in human acute cutaneous graft-versus-host disease.Transplantation,1995,60:343-348.

共引文献3

同被引文献42

  • 1Chen SJ, Zhou GB, Zhang XW, et al. From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood, 2011,117 : 6425- 6437.
  • 2Zhang XW, Yan X J, Zhou ZR, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science, 2010,328:240-243.
  • 3Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/As203 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A, 2004,101:5328-5335.
  • 4Hu J, Liu YF, Wu CF, et al. Long-term efficacy and safety of all- trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A, 2009,106:3342-3347.
  • 5Druker BJ, Guilhot F, O'Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Eng! J Med, 2006,355:2408-2417.
  • 6Kantarjian HM, Giles F, Gattermann 5/, et al. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. Blood ,2007,110:3540-3546.
  • 7Guilhot F, Apperley J, Kim DW, et al. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. Blood, 2007,109:4143-4150.
  • 8L Khoury HJ, Cortes JE, Kantarjian HM, et al. Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure. Blood, 2012, 119: 3403 -3412.
  • 9ho K, Bernardi R, Morotti A, et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature, 2008, 453 : 1072- 1078.
  • 10Yin T, Wu YL, Sun HP, et al. Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein. Blood, 2004,104:4219-4225.

引证文献3

二级引证文献34

中华内科杂志
2012年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部